(Q46732558)

24 December 2017

title

Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma (English)

1 reference

24 December 2017

0 references

0 references

1 reference

Tom C Fardon

1

1 reference

24 December 2017

Daniel K C Lee

series ordinal

2

1 reference

24 December 2017

Melissa R Hodge

series ordinal

3

1 reference

24 December 2017

Brian J Lipworth

series ordinal

4

1 reference

24 December 2017

publication date

1 September 2005

1 reference

24 December 2017

Annals of Allergy, Asthma & Immunology

published in

1 reference

24 December 2017

volume

95

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

259-265

1 reference

24 December 2017

Efficacy and safety of inhaled corticosteroids. New developments

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Inhaled steroids and the risk of hospitalization for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Low-dose inhaled corticosteroids and the prevention of death from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Repeated dosing effects of mediator antagonists in inhaled corticosteroid-treated atopic asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Antihistamines in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Are antihistamines useful in managing asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Inhibitory effect of cetirizine on cytokine-enhanced in vitro eosinophil survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Corticosteroid-sparing effect of azelastine in the management of bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Prophylactic treatment of grass pollen-induced asthma with cetirizine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Comparative in vivo bioactivity of modern H1-antihistamines on AMP challenge in atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Effects of mediator antagonism on mannitol and adenosine monophosphate challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Loss of normal cyclical beta 2 adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Caffeine decreases exhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs☆☆☆★★★

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Evaluation of cetirizine in patients with allergic rhinitis and perennial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

Comparative Effects of Desloratadine versus Montelukast on Asthma Symptoms and Use of β<sub>2</sub>-Agonists in Patients with Seasonal Allergic Rhinitis and Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961223-9

7 January 2021

10.1016/S1081-1206(10)61223-9

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mj4a7siferblrfg4227kkdg7de

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_mj4a7siferblrfg4227kkdg7de

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mj4a7siferblrfg4227kkdg7de

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/mj4a7siferblrfg4227kkdg7de

1 reference

30 July 2022